11 月，医药行业生产动能有所下降，工业增加值增速为6.6%，较10 月下降0.4 个百分点。11 月，医药行业进入消费旺季，药品零售市场需求增强，中西药品零售总额为480.1 亿元，环比增长10.9%，同比增长9.3%。受带量采购、医保控费等政策影响，医药行业利润增速进一步下滑。1～11 月，医药制造业实现利润总额2822 亿元，同比增长8.4%，增速较1～10 月下降2.0 个百分点，较上年同期下降10.0 个百分点。

The domestic market is small in Puerto Rico, per capita drug consumption is high and comparable to the US mainland which distinguishes it from other markets in the Americas. Local drug prices are significantly higher than on neighbouring islands and are more in line with US levels, having risen at an annual rate of around 3% in recent years.Strong growth in previous years has been linked to demographic and macroeconomic factors, with more innovative pharmaceuticals available in Puerto Rico than anywhere else in Latin America and the Caribbean. However, the island's poor economic prospects and the increasing number of plant closures have weakened its future growth outlook. Downward pressure due to economic recession and fiscal consolidation overall healthcare spending is expected to expand over the coming years.

According to the UN, the number of people above the age of 60 years was estimated to be 901 million in 2015. This number is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Geriatric population in Latin America and the Caribbean is expected to grow by 71.0% in the next 15 years. It has also been estimated that Asia, with a growth rate of 66.0%, will have the second largest geriatric population, followed by Africa (64.0%), North America (41.0%), and Europe (23.0%). It is also projected that by 2030, 25.0% of the European and North American population is expected to be above the age of 60years. Increasing geriatric population is expected to boost the demand for better treatment options for chronic diseases such as hyperlipidemia, hypertension, cancer, dementia, and congestive heart failure.

The only certainty in life is death. Hinged on this unique characteristic, there is a growing demand for services in the Death Care Market in the US that is ripe for disruption. For decades, the industry has been dependent on outdated business models with a hands-off approach. So far, the whole embalmed body in an open casket combined with prayers, among other (sometimes irrelevant) funeral services, have been largely predominant. However, massive cultural and religious changes, disruption in the media, and a subduing lack of fear when it comes to death have decimated the existing traditions in death care. From unique services that enable pressing cremains into diamonds to green burials, the industry is veering towards the non-traditional practices.

The Global In Vitro Diagnostics (IVD) market is categorized into five segments - product, application, technology, end-use, and regional. Product segment is categorized into instruments, reagents, and services. While technology is segmented into immunology, hematology, clinical chemistry, molecular diagnostics, coagulation, microbiology, and others. The application segment is further studied by taking into consideration therapeutic and clinical

The global contrast media injectors market has been segmented on the basis of product into injector systems and consumables. The injector system segment is further classified into CT injector systems, MRI injector systems, and cardiovascular/angiography injector systems. The consumables segment is also further divided into syringes, tubing, and others. The other consumables consist of valves, scan bags, vials, spikes, and accessories. The market is segmented on the basis of type into single head injectors, dual head injectors, and syringeless injectors. Based on the application, the market is classified into radiology, interventional cardiology, and interventional radiology. On the basis of end use, the market has been divided into hospitals, diagnostic centers, and ambulatory surgery centers. The study also comprises regional market and the key countries considered in the study are the U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Brazil, Mexico, Saudi Arabia, and South Africa.

The domestic market is small in Puerto Rico, per capita drug consumption is high and comparable to the US mainland which distinguishes it from other markets in the Americas. Local drug prices are significantly higher than on neighbouring islands and are more in line with US levels, having risen at an annual rate of around 3% in recent years.Strong growth in previous years has been linked to demographic and macroeconomic factors, with more innovative pharmaceuticals available in Puerto Rico than anywhere else in Latin America and the Caribbean. However, the island's poor economic prospects and the increasing number of plant closures have weakened its future growth outlook. Downward pressure due to economic recession and fiscal consolidation overall healthcare spending is expected to expand over the coming years.

仿制药公司的规模天花板远远低于其他医药公司，导致这一结果的最主要原因是仿制药行业集中度较低。同时在过去10年间，行业集中度没有提升的趋势。仿制药行业难以形成巨头，行业的中坚力量由大量中型企业构成。提示我们对于仿制药行业的投资，相较于不确定是否存在的龙头垄断壁垒，中小型企业的成长性更值得关注。